Fragment-Based Drug Discovery Market to be Valued at US$ 880.10 Mn by 2031; The Biopharmaceutical Companies Segment Accounts for the Largest Revenue Share| Growth Plus Reports

 | Quelle: Growth Plus Reports Growth Plus Reports

Newark, New Castle, USA, April 05, 2023 (GLOBE NEWSWIRE) -- According to the latest Growth Plus Reports study, the global fragment-based drug discovery market is projected to reach US$ 880.10 million by 2031, with a revenue CAGR of 8.60%. The study examines major growth strategies, market dynamics and prospects, rivalry, changing market environment, market size, data and forecasts, and significant investment regions.

Key Takeaways:

· The increasing prevalence of chronic conditions will drive market revenue growth.
· Increasing demand for novel drugs will drive demand for fragment-based drug discovery.
· North America dominates the global fragment-based drug discovery market. 

Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/fragmentbased-drug-discovery-market/8500

Fragment-based Drug Discovery Market Scope

Report AttributeDetails
Market size value in 2022US$ 418.8 million
Revenue forecast in 2031US$ 880.1 million
Growth RateCAGR of 8.6% from 2023 to 2031
Base year for estimation2022
Forecast Period2023-2031
Historical Year2021
Segments coveredTechnique, End-user, and Region.
Regional scopeNorth America, Europe, Asia Pacific, and the Rest of the World (ROW)

Market Drivers
The rising healthcare expenses, the frequency of chronic conditions, and the impending patent expirations of several popular drugs will drive the revenue growth of the fragment-based drug discovery market. Furthermore, growing rates of diseases like cancer, diabetes, respiratory ailments, cardiovascular diseases, and neurological disorders, and a rise in the demand for novel drugs, will boost the market revenue growth rate. Apart from this, an increasing number of illnesses, such as diabetes, cancer, and cardiovascular conditions, are expected to support the market's revenue growth.

Market Segmentation
Growth Plus Reports has analyzed the global fragment-based drug discovery market from four perspectives: Technique, End-user, and Region. 

Technique Segmentation: Based on the technique, the fragment-based drug discovery market is segmented into biophysical and non-biophysical techniques. The biophysical technique segment dominates the market with the largest revenue share because Biophysical methods are critical in fragment-based drug discovery to hit identification and validation.

End-User Segmentation: Based on the end-user, the fragment-based drug discovery market is segmented into biopharmaceutical companies, CROs, and academic and research institutions. The biopharmaceutical companies segment dominates the market because there are many uses for fragment-based drug discovery techniques in the biopharmaceutical sector. These techniques have significantly improved the success rate of synthesis over conventional screening techniques, which helps develop chemical series with properties similar to those of lead.

Regional Growth Dynamics
Based on the region, the global fragment-based drug discovery market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. 

North America dominates the global fragment-based drug discovery market with the largest revenue share. Growing demand for biologics, improved healthcare facilities, increased expenditure on research and development, the prevalence of chronic diseases, and a significant number of major drug development firms in this region are the major factors responsible for North America's significant revenue share in the global market.  

Request for Customization – https://www.growthplusreports.com/inquiry/customization/fragment-based-drug-discovery-market/8500

Competitive Landscape

The prominent players operating in the global fragment-based drug discovery market are:

  1. Astex Pharmaceuticals
  2. Alveus Pharmaceuticals Pvt. Ltd.
  3. Beactica AB
  4. Charles River Laboratories International, Inc.
  5. Crown Biosciences, Inc.
  6. Emerald BioStructures, Inc.
  7. Evotec AG
  8. Kinetic Discovery limited
  9. Proteros Fragments GmbH
  10. Sprint Biosciences
  11. Structure Based Design, Inc.
  12. Sygnature Discovery

The fragment-based drug discovery market is competitive with several global corporations. Leading players invest in technological advancements, research and development, and mergers and acquisitions to strengthen their market position.

Recent developments:

  1. Astex Pharmaceuticals and Cardiff University's Medicines Discovery Institute announced in February 2023 that they had collaborated on a multi-year, multi-million-pound drug discovery research project to identify new drugs to treat neurodegenerative diseases.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape
    4. Reimbursement Scenario 
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET - ANALYSIS & FORECAST, BY TECHNIQUE
    1. Biophysical Techniques
      1. NMR Spectroscopy
      2. DSF Assay 
      3. Fluorescence Polarization 
      4. Isothermal Titration Calorimetry
      5. X-ray Crystallography 
      6. SPR 
      7. Biolayer Interferometry
      8. Mass Spectrometry 
      9. Capillary Electrophoresis
      10. Others
    2. Non-biophysical Techniques
  6. GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET - ANALYSIS & FORECAST, BY END-USER
    1. Biopharmaceutical Companies
    2. CROs
    3. Academic and Research Institutions

FRAGMENT-BASED DRUG DISCOVERY MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8500

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse Latest Healthcare Related Reports:

Medical Coding Market by Classification System (International Classification of Diseases (ICD)), Component (Outsourced), End User (Hospital) – Global Outlook & Forecast 2023-2031

Interventional X-Ray Contrast Systems Market by Product Type (Iodinated Contrast-Media, Gadolinium-Based Contrast Media), Application (Cardiology, Neurology, Oncology)-Global Outlook & Forecast 2023-2031

Foot and Ankle Plating System Market by Application (Ankle Fusion, Forefoot & Midfoot Fusion), Material (Stainless Steel Plates, Titanium Plates), End User (Hospitals, Orthopedic Centers) – Global Outlook & Forecast 2023-2031

Facet Joint Injections Market by Product Type (Local Anesthesia, Steroids), Application (Cervical Facet Joints, Lumber Facet Joints), End User (Hospitals, Outpatient Centers) - Global Outlook and Forecast 2023-2031

Enteral Feeding Devices Market by Product (Enteral Feeding Pumps, Enteral Feeding Tubes, Enterostomy Feeding Tubes, Nasoenteric Feeding Tubes), Age Group (Pediatrics, Adults) Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care), End User (Hospitals & Home Care) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

 

            








        

            

                

                    
Tags

                            
                                Fragment-Based Drug Discovery
                            

                



        


    

        
Weiterführende Links

        
    



    

        

        
Kontaktdaten